Humatrope and Otitis - a phase IV clinical study of FDA data

Summary:

Otitis is reported as a side effect among people who take Humatrope (somatropin recombinant), especially for people who are male, 2-9 old, also take Synthroid, and have Blood growth hormone abnormal.

The phase IV clinical study analyzes which people have Otitis when taking Humatrope. It is created by eHealthMe based on reports of 7,889 people who have side effects when taking Humatrope from the FDA, and is updated regularly.

What is Humatrope?

Humatrope has active ingredients of somatropin recombinant. It is often used in stature short abnormal. eHealthMe is studying from 7,932 Humatrope users. Check the latest studies of Humatrope.

What is Otitis?

Otitis (ear infection) is found to be associated with 1,412 drugs and 1,834 conditions by eHealthMe. Check the latest studies of Otitis.

On Jul, 30, 2026

7,889 people reported to have side effects when taking Humatrope.
Among them, 14 people (0.18%) have Otitis.

Among these 14 people:

What is the gender of people who have Otitis when taking Humatrope? *

female: 50 %
male: 50 %

What is the age of people who have Otitis when taking Humatrope? *

What are other drugs people take besides Humatrope? *

What are other side effects people have besides Otitis? *

Acidosis (build-up of carbon dioxide in the blood): 2 people, 14.29%
Post Procedural Complication: 2 people, 14.29%
Haemoglobin Decreased: 2 people, 14.29%
Haematoma (collection of blood outside the blood vessels): 2 people, 14.29%
Haematocrit Decreased: 2 people, 14.29%
Glomerulonephritis Membranoproliferative (a type of glomerulonephritis caused by deposits in the kidney glomerular mesangium and basement membrane (gbm) thickening): 2 people, 14.29%
Flank Pain (a distressing sensation experienced around the lower back and the upper abdomen): 2 people, 14.29%
Blood Chloride Increased: 2 people, 14.29%
Renal Tubular Atrophy (wasting of kidney tubules): 2 people, 14.29%
Sinusitis (inflammation of sinus): 2 people, 14.29%

What are the existing conditions these people have? *

Hypothalamo-Pituitary Disorder (loss of function in an endocrine gland due to failure of the pituitary gland to secrete hormones which stimulate that gland's function): 1 person, 7.14%
Hypopituitarism (diminished hormone secretion by the pituitary gland, causing dwarfism in children and premature aging in adults): 1 person, 7.14%
Cytogenetic Abnormality: 1 person, 7.14%
Body Height Below Normal: 1 person, 7.14%
Blood Growth Hormone Abnormal: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Humatrope and have Otitis?

- Check whether Otitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Humatrope:

Humatrope (7,932 reports)

Otitis treatments and more:

Otitis (36,446 reports)

Browse all side effects of Humatrope:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Otitis:

Otitis (1,412 drugs)

Browse all the conditions that are associated with Otitis:

Otitis (1,834 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on somatropin recombinant (the active ingredients of Humatrope) and Humatrope (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.